Shenzhen Salubris Pharmaceuticals Co. Ltd. (002294)
SZSE
Closed
Sep 18, 2026
Day's Range
30.1252 wk Range
29.25Profile - 002294 - Shenzhen Salubris Pharmaceuticals Co. Ltd.
Profile
Mic Code
XSHE
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Employees
4.08K
Shenzhen Salubris Pharmaceuticals Co. Ltd. is a prominent entity in the pharmaceutical industry, primarily engaged in the research, development, production, and sale of a wide range of medicinal products. Its extensive portfolio includes cardiovascular drugs, antibiotics, orthopedics preparations, and central nervous system medications, among others. This company plays a critical role in the healthcare sector by focusing on the creation of innovative treatment solutions that address various medical needs. Operating at the intersection of cutting-edge pharmaceutical technology and clinical development, Shenzhen Salubris Pharmaceuticals also collaborates with global healthcare partners to enhance its research capabilities and expand its product offerings. The company's dedication to providing quality healthcare solutions is evident in its commitment to maintaining high standards across its manufacturing and distribution processes. Positioned within the dynamic Chinese pharmaceutical market, Shenzhen Salubris Pharmaceuticals continues to impact both the domestic and international healthcare landscapes. As it leverages new scientific advancements and regulatory policies, the company is well-positioned to further contribute to the evolving needs of global patient care.
Profile Details
Type
Common Stock
Address
No. 289 Digital Peninsula
City
Shenzhen
Zip
518017
Country
China
Phone
86 755 8386 7888
Key Executives - 002294 - Shenzhen Salubris Pharmaceuticals Co. Ltd.
Key executives
Cross Listings - 002294 - Shenzhen Salubris Pharmaceuticals Co. Ltd.
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
